Found 54 matching trials
Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer
PHASE3The purpose of this study is to evaluate the effectiveness of anti-HER2 the...
Location
Sun Yat-sen University Cancer Center
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer
PHASE1The main purpose of this research study is to learn whether the investigati...
Location
Abramson Cancer Center of the University of Pennsylvania
A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale
PHASE2This is a 4-arm study to evaluate and compare bleeding patterns between thr...
Location
Duramed Investigational Site
A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland
NAObjective is to characterize epidemiology, clinical and genetic features of...
Location
Hospital for Children and Adolescents, Helsinki University Central Hospital
Continuous Versus Cyclic Use of Oral Contraceptive Pills in Adolescents
PHASE3The primary purpose of this study is to compare the compliance rates of ado...
Location
The Hospital for Sick Children
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment
PHASE2The purpose of this study is to see if the combination of chemotherapy drug...
Location
Dana-Farber Cancer Institute
Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache
PHASE3The aim of the present study is to investigate whether women taking a new c...
Location
Multiple Locations
Menopausal Sleep Fragmentation and Body Fat Gain
PHASE4This study aims to investigate the impact of menopause-related sleep fragme...
Location
Brigham & Women's Hospital
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
PHASE3The objectives of this randomized withdrawal study are to evaluate the long...
GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer
PHASE1The primary objectives of the Phase 1b Dose Escalation part of this study a...
Location
Stanford Women's Cancer Center